News Quantified

GH – guardant health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Guardant Health (NASDAQ:GH) had its price target raised by analysts at BTIG Research from $100.00 to $140.00. They now have a "buy" rating on the stock.

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. [Yahoo! Finance]

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

27.9%

BEAT

-9.3%

BEAT

3.5%

BEAT

-13.7%

BEAT

Form 4 Guardant Health, Inc. For: Dec 08 Filed by: Talasaz AmirAli

Form 4 Guardant Health, Inc. For: Dec 08 Filed by: Kalia Kumud

Form 4 Guardant Health, Inc. For: Dec 08 Filed by: Chudova Darya

Form 4 Guardant Health, Inc. For: Dec 08 Filed by: Hidalgo Medina Manuel

Form 4 Guardant Health, Inc. For: Dec 05 Filed by: Freeman Chris

Top News Gainers

8/6 Q2/2019 6/30/2019 EPS -0.130 ZacksConsensus -0.340 ActVsEst 0.210 - Beat 20.5%

5/9 Q1/2019 3/31/2019 EPS -0.300 ZacksConsensus -0.350 ActVsEst 0.050 - Beat 18.6%

2/27 Form 4 Guardant Health, Inc. For: Feb 25 Filed by: CLARK IAN T 12.9%

3/3 Form 4 Guardant Health, Inc. For: Feb 28 Filed by: Nishar Dipchand 12.4%

11/7 Q3/2019 9/30/2019 EPS -0.140 ZacksConsensus -0.390 ActVsEst 0.250 - Beat 12.2%

3/25 Form 4 Guardant Health, Inc. For: Mar 23 Filed by: BERTOCCI DEREK A 8.0%

2/25 Guardant Health Inc (GH) Q4 2019 Earnings Call Transcript [The Motley Fool] 7.5%

5/23 Form EFFECT Guardant Health, Inc. 6.5%

2/11 Form 4/A Guardant Health, Inc. For: Dec 20 Filed by: Talasaz AmirAli 6.3%

4/9 Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer 6.3%

Top News Decliners

3/15 Coronavirus Bear Market: Where to Invest $5,000 Right Now [The Motley Fool] -12.6%

3/6 Form 4 Guardant Health, Inc. For: Mar 04 Filed by: Kaul Samir -11.3%

2/24 Q4/2019 12/31/2019 EPS -0.270 ZacksConsensus -0.300 ActVsEst 0.030 - Beat -10.2%

2/28 Form 4 Guardant Health, Inc. For: Feb 26 Filed by: Kaul Samir -9.2%

5/8 The Wall Street Journal: SoftBank’s Vision Fund positioned for big haul in Uber IPO [MarketWatch] -7.5%

8/8 Guardant Health Inc (NASDAQ: GH) was given a new $110.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -6.9%

5/10 Form 4 Guardant Health, Inc. For: May 10 Filed by: BERTOCCI DEREK A -6.0%

3/11 Guardant Health Inc (NASDAQ: GH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.0%

10/5 3 Top Healthcare Stocks to Buy in October [The Motley Fool] -6.0%

9/13 Form 4 Guardant Health, Inc. For: Sep 11 Filed by: SVF Endurance (Cayman) Ltd -5.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day